Cathie Wood acquired 11.5 Million Fate Therapeutics shares worth $260 Million. That's 1.90% of their equity portfolio (19th largest holding). The investor owns 12.00% of the outstanding Fate Therapeutics stock. The first Fate Therapeutics trade was made in Q4 2019. Since then Cathie Wood bought shares nine more times and sold shares on one occasions. The investor's estimated purchase price is $820 Million, resulting in a loss of 68%.
Source: ra2 studio/Shutterstock Shares of Fate Therapeutics (NASDAQ: FATE ) stock are up 3% following a massive purchase by two of Cathie Wood’s exchange-tra...InvestorPlace, about 2 months ago
Positive news versus poor clinical trial results may determine the future of Fate Therapeutics.The Motley Fool, about 1 year ago